SIRIC - Institut Curie
Our ambition with the SIRIC program is to connect multidisciplinary research with state of the art medical care to solve the question of resistance to anti-cancer treatment.
Patients are at the heart of the SIRIC program. Are you a patient or a patient relative?
Who are we?
SIRIC is a national translational research label awarded by the French National Cancer Institute (INCa) as part of the Cancer Plan. Institut Curie was labeled in 2011, 2018 and 2023.
SIRICs are multidisciplinary research sites where different research dimensions are united (fundamental, clinical, public health, epidemiology, human and social sciences) and where the critical mass of doctors, patients, researchers, are committed to the constraints – notably competitiveness and quality – of translational research.